# TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

> **NCT04294888** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 4 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Aging

## Interventions

- **DEVICE:** repetitive transcranial magnetic stimulation (rTMS)

## Key facts

- **NCT ID:** NCT04294888
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-02
- **Primary completion:** 2021-06-23
- **Final completion:** 2021-06-23
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The study principle investigator left the institution.
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294888, "TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT04294888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*